• 2020 Date Announced: The 4th Annual US E-Cigarette Summit will take place May 4 2020


Science, Regulation and Public Health

Smoking is the biggest single cause of preventable death in the developed world with almost 1 billion users worldwide. The devastating effect of long-term smoking cannot be underestimated, with approximately half of all lifetime smokers dying from smoking related diseases and many more suffering a compromised quality of life.  Despite decades of successful tobacco control efforts, we are still a long way from ending the smoking epidemic.

The emergence of e-cigarettes, which deliver nicotine but without the vast range of carcinogens and toxins found in combustible tobacco products has created one of the most controversial and contentious public health issues of a generation, with divisions appearing within longstanding professional alliances in both Tobacco Control and Public Health communities, despite a continued shared goal of protecting public health and ending the smoking epidemic.

The E-Cigarette Summit provides a  neutral platform to explore the available peer reviewed evidence and debate the issues that are dividing scientists, health professionals and policy makers alike. So, are-cigarettes a valuable harm reduction strategy or a tacit U-turn on decades of effective tobacco control efforts? Whichever side of the debate you fall on, this is likely to be one of the most significant public health issues for a generation.

2019 Key Topics include:

  • What are the key considerations for prudent regulation of e-cigarettes?
  • How do we maximize benefits for smokers and minimize potential harms for youth?
  • Understanding youth use – how should data be interpreted and presented?
  • How do we educate youth without confusing adult smokers
  • How should the evidence on e-cigarettes and the harm continuum be communicated to the American public – how can we better help the public understand relative risks?
  • Is the current and proposed regulatory regime for e-cigarettes fit for purpose or does it need to be reformed and, if so, what needs to be considered to achieve maximum benefits for public health?
  • Are American youth experimenting with e-cigarettes more than other countries – what are the appropriate measures?
  • Is dual use an important step in cessation or a failing of harm reduction?
  • What direction should the FDA take with e-cigarettes and tobacco control – what are the main priorities for current smokers?  And for preventing youth initiation?  Are these two priorities compatible?
  • Current and future research priorities
  • Why has tobacco harm reduction proved to be such a divisive issue – how can we improve dialogue and collaboration?
  • Nicotine reduction – harm reduction not prohibition
  • The Australian experience with e-cigarettes
  • Evolution of the regulatory framework in the UK
  • The impact of E-Cigarette regulation
  • Safety concerns with E-Cigarettes
  • Prevention and protection policies for youth use of E-Cigarettes and tobacco products
  • Switching from combustibles to E-Cigarettes
  • How to make sense of the flavors issue
  • Smoking harm reduction – if not now, when?

2019 Confirmed Speakers/Panel Presenters

Tony AbboudExecutive Director, Vapor Technology AssociationRachelle AnnechinoAssociate Research Scientist, Critical Public Health Research Group/PIRE Prevention Research Center
Deborah ArnottChief Executive, Action on Smoking and Health (UK)Clive BatesDirector, Counterfactual Consulting Ltd
Alex ClarkChief Executive Officer, CASAACliff Douglas JDVice President, Tobacco Control, Director, Center for Tobacco Control, American Cancer Society
Stacy L. EhrlichPartner, Kleinfeld Kaplan & Becker LLPProf Jonathan FouldsProfessor of Public Health Sciences and Psychiatry, Penn State Tobacco Center of Regulatory Science, Cancer Institute
Prof Peter HajekProfessor of Clinical Psychology, Queen Mary University of LondonProf David Hammond, PhDProfessor & CIHR/PHAC Applied Public Health Chair, University of Waterloo, Ontario
Dr Cheryl G. Healton Dr.PHDean and Professor, NYU College of Global Public HealthProf Thomas J. Glynn, PhDAdjunct Lecturer, Stanford Prevention Research Centre, Stanford University School of Medicine
Dr Brian King PhD, MPHDeputy Director for Research Translation, Office on Smoking and Health, Centers for Disease Control and PreventionProf David LevyProfessor of Oncology, Lombardl Comprehensive Cancer Center, Georgetown University
Eric N. Lindblom, JDDirector, Tobacco Control and Food & Drug Law, O'Neill Institute for National and Global Health Law, Georgetown LawProfessor Ann McNeillProfessor of Tobacco Addiction, UK Centre for Tobacco and Alcohol Studies (UKCTAS), Kings College London
Colin MendelsohnConjoint Associate Professor, University of New South Wales, SyndeyDr Robin MermelsteinProfessor of Psychology and IHRP Director, University of Illinois, Chicago
AG Tom MillerAttorney General of IowaMatthew L. MyersPresident, Campaign for Tobacco-Free Kids
Dr. Nancy A. Rigotti, MDProfessor of Medicine, Harvard Medical School, Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, BostonProf Steven A. Schroeder MDDistinguished Professor of Health and Healthcare, University of California, San Francisco & Director, Smoking Cessation Leadership Center
Dr. Lion ShahabAssociate Professor in Health Psychology, University College LondonJames Van LoonDirector General, Tobacco Control Directorate, Health Canada
Prof Kenneth WarnerProfessor Emeritus and Dean Emeritus, School of Public Health, University of Michigan